Chugai Pharmaceutical Co Stock Performance
| CHGCY Stock | USD 28.64 0.09 0.32% |
On a scale of 0 to 100, Chugai Pharmaceutical holds a performance score of 14. The firm shows a Beta (market volatility) of 0.7, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Chugai Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chugai Pharmaceutical is expected to be smaller as well. Please check Chugai Pharmaceutical's skewness, and the relationship between the value at risk and day median price , to make a quick decision on whether Chugai Pharmaceutical's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Chugai Pharmaceutical Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Chugai Pharmaceutical showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 212.3 B | |
| Total Cashflows From Investing Activities | -118.9 B |
Chugai |
Chugai Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,295 in Chugai Pharmaceutical Co on November 5, 2025 and sell it today you would earn a total of 569.00 from holding Chugai Pharmaceutical Co or generate 24.79% return on investment over 90 days. Chugai Pharmaceutical Co is currently producing 0.3927% returns and takes up 2.1732% volatility of returns over 90 trading days. Put another way, 19% of traded pink sheets are less volatile than Chugai, and 93% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Chugai Pharmaceutical Target Price Odds to finish over Current Price
The tendency of Chugai Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 28.64 | 90 days | 28.64 | under 4 |
Based on a normal probability distribution, the odds of Chugai Pharmaceutical to move above the current price in 90 days from now is under 4 (This Chugai Pharmaceutical Co probability density function shows the probability of Chugai Pink Sheet to fall within a particular range of prices over 90 days) .
Chugai Pharmaceutical Price Density |
| Price |
Predictive Modules for Chugai Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Chugai Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chugai Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Chugai Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Chugai Pharmaceutical is not an exception. The market had few large corrections towards the Chugai Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Chugai Pharmaceutical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Chugai Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.38 | |
β | Beta against Dow Jones | 0.70 | |
σ | Overall volatility | 1.24 | |
Ir | Information ratio | 0.17 |
Chugai Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Chugai Pink Sheet often depends not only on the future outlook of the current and potential Chugai Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chugai Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.3 B | |
| Cash And Short Term Investments | 472 B |
Chugai Pharmaceutical Fundamentals Growth
Chugai Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Chugai Pharmaceutical, and Chugai Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chugai Pink Sheet performance.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.42 % | |||
| Current Valuation | 39.67 B | |||
| Shares Outstanding | 3.29 B | |||
| Price To Earning | 22.15 X | |||
| Price To Book | 4.62 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 999.76 B | |||
| EBITDA | 419.43 B | |||
| Cash And Equivalents | 545.3 B | |||
| Cash Per Share | 165.74 X | |||
| Total Debt | 16.04 B | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 432.94 X | |||
| Cash Flow From Operations | 279.63 B | |||
| Earnings Per Share | 0.86 X | |||
| Total Asset | 1.54 T | |||
| Retained Earnings | 500.19 B | |||
| Current Asset | 542.89 B | |||
| Current Liabilities | 107.7 B | |||
About Chugai Pharmaceutical Performance
Evaluating Chugai Pharmaceutical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Chugai Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chugai Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. CHUGAI PHARMACEUTICAL operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.Things to note about Chugai Pharmaceutical performance evaluation
Checking the ongoing alerts about Chugai Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Chugai Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Chugai Pharmaceutical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Chugai Pharmaceutical's pink sheet performance include:- Analyzing Chugai Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chugai Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Chugai Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chugai Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chugai Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chugai Pharmaceutical's pink sheet. These opinions can provide insight into Chugai Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Chugai Pink Sheet Analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.